Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valeo Pharma Inc T.VPH.DB


Primary Symbol: T.VPH Alternate Symbol(s):  VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Recent & Breaking News (TSX:VPH)

VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

Canada NewsWire 9 days ago

VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE

Canada NewsWire April 9, 2024

VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS

Canada NewsWire March 22, 2024

VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS

Canada NewsWire March 14, 2024

VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST

Canada NewsWire March 7, 2024

VALEO PHARMA ANNOUNCES BOARD OF DIRECTORS CHANGES

Canada NewsWire February 13, 2024

VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP

Canada NewsWire February 2, 2024

VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL YEAR 2023

Canada NewsWire January 29, 2024

VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCAST

Canada NewsWire January 22, 2024

VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND COST REDUCTION INITIATIVES

Canada NewsWire November 20, 2023

VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORS

Canada NewsWire November 7, 2023

VALEO PHARMA MAKES THE LIST OF THE GLOBE AND MAIL'S FIFTH-ANNUAL RANKING OF CANADA'S TOP GROWING COMPANIES

Canada NewsWire October 4, 2023

VALEO PHARMA ENTERS INTO $5 MILLION CREDIT FACILITY AGREEMENT WITH ACCORD FINANCIAL INC.

Canada NewsWire September 27, 2023

VALEO PHARMA REPORTS RECORD THIRD QUARTER 2023 REVENUES

Canada NewsWire September 13, 2023

VALEO PHARMA TO HOST THIRD QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST

Canada NewsWire September 7, 2023

VALEO PHARMA CLOSES $4.5 MILLION FINANCING

Canada NewsWire August 31, 2023

VALEO PHARMA PROVIDES UPDATE ON OPHTHALMOLOGY BUSINESS UNIT

Canada NewsWire July 4, 2023

VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTS

Canada NewsWire June 22, 2023

VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES

Canada NewsWire June 13, 2023

VALEO PHARMA TO HOST SECOND QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST

Canada NewsWire June 7, 2023